Stocks Health care ACH
NYSE · Health careAccendra Health Inc (ACH)
Accendra Health Inc brought in $2.6B of revenue over the twelve months to June 30, 2026, up 247.0% from a year earlier. It posted a net loss of $302.1M. In fiscal 2025 capital spending exceeded operating cash flow by $292.7M. At June 30, 2026 it held $7.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
Key facts about Accendra Health Inc
- Net worth
- Accendra Health Inc has a market value (market cap) of $11.1M at the latest share price, and shareholders' equity of -$550.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $2.8B (+3.1% year on year), with a net loss of $1.1B. Over the 12 months to June 30, 2026: revenue $2.6B, net loss $302.1M.
- Cash flow
- In fiscal 2025 operations used $101.8M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 10, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Accendra Health Inc's next report was expected around October 29, 2026 and is not on file with the SEC yet.
What Accendra Health Inc does
Accendra Health Inc is registered with the SEC under industry code SIC 5047 (Wholesale-Medical, Dental & Hospital Equipment & Supplies). Its shares trade on NYSE under the ticker ACH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.8B | -$1.1B | -$14.31 | -$292.7M |
| 2024 | $2.7B | -$362.7M | -$4.73 | -$8.8M |
| 2023 | $2.6B | -$41.3M | -$0.53 | $568.3M |
| 2022 | $10B | $22.4M | $0.29 | $166.9M |
| 2021 | $9.8B | $221.6M | $2.94 | $83.2M |
| 2020 | $8.5B | $29.9M | $0.47 | $288.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ACH ranks in Health care
Dividends
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2023 | n/a | $0 | n/a |
| 2022 | n/a | $0 | 0% |
| 2021 | $0.01 | $731K | 0% |
| 2020 | $0.01 | $648K | 2% |
| 2019 | $0.01 | $5.2M | n/a |
| 2018 | $0.86 | $48.2M | n/a |
Latest SEC filings
What Accendra Health Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 28, 2026Executive or director change8-K/AAccendra Health set October 5, 2026 as the start date for incoming CEO Kenneth Gardner-Smith and signed a consulting agreement with outgoing CEO Edward A. Pesicka.
- September 17, 2026Executive or director change8-KAccendra Health appointed Kenneth Gardner-Smith as President and CEO and named Scott Lloyd as Chief Commercial Officer.
- August 17, 2026
- August 10, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 10% to $613.2M versus the same quarter last year; diluted EPS -$1.16 versus -$11.30.
- August 10, 2026
- August 10, 2026
- July 15, 2026
- June 25, 2026Other event 8-K
- June 15, 2026
Insider trades
What the people running Accendra Health Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 5, 2026 | Gardner-Smith KennethPresident & CEO, Director | Received as pay | 283,554 | - |
| September 23, 2026 | Leon Jonathan AEVP & CFO | Shares withheld for tax | 4,265 | $3.6K |
| May 18, 2026 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax | 1,822 | $5.3K |
| May 15, 2026 | Bernocchi Perry AEVP, Chief Operating Officer | Shares withheld for tax | 7,908 | $24K |
| May 15, 2026 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax | 966 | $2.9K |
| May 15, 2026 | Pesicka Edward APresident & CEO, Director | Shares withheld for tax | 17,692 | $53.8K |
| May 15, 2026 | Leon Jonathan AEVP & CFO | Shares withheld for tax | 1,770 | $5.4K |
| May 14, 2026 | Beck Mark ADirector | Received as pay | 31,191 | - |
Who owns ACH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Coliseum Capital Management, LLC13D, may seek influence with 4 related filers | 16.9% | November 14, 2025 |
| Kevin M. Webb13G, passive | 5.61% | March 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 140 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Coliseum Capital Management, LLC | 13,100,807 | 0 |
| BlackRock, Inc. | 5,504,102 | +268,802 |
| Bank of America Corp | 3,775,525 | +368,450 |
| Vanguard Capital Management LLC | 3,087,931 | -194,243 |
| D. E. Shaw & Co., Inc. | 3,081,407 | -230,194 |
| Charles Schwab Investment Management Inc | 2,888,058 | -747,468 |
| Invenomic Capital Management LP | 2,812,474 | -556,501 |
| Marshall Wace, Llp | 2,582,579 | +821,575 |
| Paradigm Capital Management Inc | 2,536,699 | +750,299 |
| Vanguard Portfolio Management LLC | 2,030,956 | -620,196 |
| Dana Investment Advisors, Inc. | 1,944,607 | +459,510 |
| Geode Capital Management, LLC | 1,873,127 | +37,217 |
| Dimensional Fund Advisors LP | 1,640,163 | -966,457 |
| State Street Corp | 1,601,162 | -28,794 |
| Connor, Clark & Lunn Investment Management Ltd. | 1,288,787 | -91,941 |
| Aqr Capital Management LLC | 1,067,324 | +335,103 |
| Goldman Sachs Group Inc | 854,730 | -86,443 |
| Two Sigma Investments, LP | 718,550 | -482,719 |
| Northern Trust Corp | 581,804 | -19,157 |
| Wolverine Asset Management LLC | 568,084 | -127,331 |
Insiders
9 insiders reported holding 2,669,820 shares in total, about $384.5K at the last price.
| Holder | Shares |
|---|---|
| Pesicka Edward APresident & CEO, Director | 1,072,785 |
| Gardner-Smith KennethPresident & CEO, Director | 369,667 |
| Bernocchi Perry AEVP, Chief Operating Officer | 313,913 |
| Leon Jonathan AEVP & CFO | 286,268 |
| Long Andrew GEVP, CEO P&HS | 214,064 |
| Galloway Heath HEVP,General Counsel & CorpSecy | 166,306 |
| Klemash Stephen WDirector | 90,242 |
| Kline Teresa L.Director | 85,316 |
| Beck Mark ADirector | 71,259 |
Questions about ACH
What does Accendra Health Inc do?
Accendra Health Inc is a company in the Health care sector, listed on NYSE as ACH. Its shares trade on NYSE under the ticker ACH.
What is Accendra Health Inc's net worth?
Accendra Health Inc has a market value (market cap) of $11.1M at the latest share price, and shareholders' equity of -$550.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Accendra Health Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $302.1M on revenue of $2.6B.
How much revenue does Accendra Health Inc make?
Over the twelve months to June 30, 2026 Accendra Health Inc reported revenue of $2.6B. That is 247.0% more than a year earlier.
When did Accendra Health Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 6, 2026.
When is Accendra Health Inc's next earnings report?
Accendra Health Inc's next report was expected around October 29, 2026 and is not on file with the SEC yet.
Similar companies
Compare ACH with
Follow ACH
Get an email when Accendra Health Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Accendra Health Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.